The expression of CD169 was however not seen in the other TNBC xenograft using MDA-MB-231 cells (Supplementary Figure 1A), indicating that different TNBC tumor cells and microenvironments may have different effects on CD169 upregulation. This evidence concerns the gene SIGLEC1 and neoplasm.